Literature DB >> 6524900

Enhancement of the in vitro activity of amphotericin B against Aspergillus spp. by tetracycline analogs.

C E Hughes, C Harris, L R Peterson, D N Gerding.   

Abstract

Strains of Aspergillus fumigatus, Aspergillus flavus, and Aspergillus niger were tested for in vitro susceptibility to amphotericin B alone and in combination with fixed concentrations of tetracycline, doxycycline, or minocycline, using buffered minimal essential medium in microtiter plates. Enhanced inhibitory activity was seen, especially with combinations of amphotericin B and minocycline. Synergistic activity between amphotericin B and minocycline was observed in each of five isolates of each species when tested in a checkerboard dilution scheme. Time-kill curves demonstrated killing an A. fumigatus isolated at concentrations of amphotericin B that were four- or eightfold lower in the presence of 5 or 15 micrograms of minocycline per ml than with amphotericin B alone. Of the tetracycline analogs tested, minocycline has the greatest activity against A. fumigatus, A. flavus, and A. niger conidia when potentiated by amphotericin B.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6524900      PMCID: PMC180035          DOI: 10.1128/AAC.26.6.837

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Effect of tetracycline on the phagocytic function of human leukocytes.

Authors:  A Forsgren; D Schmeling; P G Quie
Journal:  J Infect Dis       Date:  1974-10       Impact factor: 5.226

2.  Combined amphotericin B-tetracycline therapy for experimental coccidioidomycosis.

Authors:  M Huppert; S H Sun; K R Vukovich
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

Review 3.  Antibiotic interaction with model membranes.

Authors:  S C Kinsky
Journal:  Annu Rev Pharmacol       Date:  1970       Impact factor: 13.820

4.  Therapy of murine aspergillosis with amphotericin B in combination with rifampin of 5-fluorocytosine.

Authors:  J Arroyo; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

5.  Activity of amphotericin B, 5-fluorocytosine, and rifampin against six clinical isolates of Aspergillus.

Authors:  M Kitahara; V K Seth; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

6.  In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp.

Authors:  C E Hughes; C Harris; J A Moody; L R Peterson; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

7.  In-vitro effects of Candida albicans of amphotericin B combined with other antibiotics. Preliminary observations.

Authors:  S Anséhn; S Granström; H Höjer; L Nilsson; E Akesson; A Lundin; A Thore
Journal:  Scand J Infect Dis Suppl       Date:  1976

8.  Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).

Authors:  G Medoff; G S Kobayashi; C N Kwan; D Schlessinger; P Venkov
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

9.  Antifungal activity of four tetracycline analogues against Candida albicans in vitro: potentiation by amphotericin B.

Authors:  M A Lew; K M Beckett; M J Levin
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

10.  Potentiation of the antifungal effects of antibiotics by amphotericin B.

Authors:  C N Kwan; G Medoff; G S Kobayashi; D Schlessinger; H J Raskas
Journal:  Antimicrob Agents Chemother       Date:  1972-08       Impact factor: 5.191

View more
  8 in total

1.  Multifactorial analysis of effects of interactions among antifungal and antineoplastic drugs on inhibition of Candida albicans growth.

Authors:  M A Ghannoum; M S Motawy; M A Abu Hatab; A S Ibrahim; R S Criddle
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

2.  Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection.

Authors:  S C Harris; J E Wallace; G Foulds; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

3.  In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum.

Authors:  Francielli P K Jesus; Laerte Ferreiro; Érico S Loreto; Maiara B Pilotto; Aline Ludwig; Karine Bizzi; Juliana S M Tondolo; Régis A Zanette; Sydney H Alves; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2014-07-07       Impact factor: 5.191

4.  Microbiological diagnosis of suppurative keratitis in Bangladesh.

Authors:  G Williams; F Billson; R Husain; S A Howlader; N Islam; K McClellan
Journal:  Br J Ophthalmol       Date:  1987-04       Impact factor: 4.638

5.  In Vitro and In Vivo Study on the Synergistic Effect of Minocycline and Azoles against Pathogenic Fungi.

Authors:  Lujuan Gao; Yi Sun; Mingzhu Yuan; Ming Li; Tongxiang Zeng
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

6.  In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans.

Authors:  Javier Afeltra; Eric Dannaoui; Jacques F G M Meis; Juan L Rodriguez-Tudela; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

7.  Doxycycline-regulated gene expression in the opportunistic fungal pathogen Aspergillus fumigatus.

Authors:  Keith Vogt; Ruchi Bhabhra; Judith C Rhodes; David S Askew
Journal:  BMC Microbiol       Date:  2005-01-13       Impact factor: 3.605

Review 8.  Techniques for the Assessment of In Vitro and In Vivo Antifungal Combinations.

Authors:  Anne-Laure Bidaud; Patrick Schwarz; Guillaume Herbreteau; Eric Dannaoui
Journal:  J Fungi (Basel)       Date:  2021-02-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.